Home

Hans van Houte, CFO: Nurix Therapeutics NRIX Sell · Filed 25/07/30

Trade details

Type
Insider sale
Amount
$51,691.04
Shares · price
4,304 sh · $12.01 a share
Held after
40,914 sh
Trade date
25/07/30
Filed
25/07/30
Days to filing
0 days

Sold 9.5% of holdings

Share of holding sold
9.5%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 25/06/30~25/08/29

Hans van Houte's recent trades

  • Hans van Houte

    Planned sale10b5-1 planNurix Therapeutics

    $110.6K

    Filed 08/04

  • Hans van Houte

    Sell10b5-1 planNurix Therapeutics

    $223.4K

    Filed 05/05

  • Hans van Houte

    Sell10b5-1 planNurix Therapeutics

    $9,999

    Filed 05/05

  • Hans van Houte

    Planned sale10b5-1 planNurix Therapeutics

    $238K

    Filed 05/05

  • Hans van Houte

    SellNurix Therapeutics

    $39.8K

    Filed 04/30